BC Partners, a private equity investment firm, agreed to acquire Havea, a natural healthcare company, from 3i Group, a multinational investor, and Cathay Capital, a private equity firm. Financial terms were not disclosed. Havea benefits from long-term structural tailwinds, and embodies the key themes that we look for in a healthcare business, particularly in pharma, of providing strong value to patients and healthcare payors alike, preventative care, and digitalisation. Havea has an outstanding track record of delivery, true market leadership, and a best-in-class management team, which are key criteria we seek in our investments. We look forward to working with the management team in realising the full potential of the Group,” Mark Hersee, BC Partners Partner.